DOI QR코드

DOI QR Code

Effect of Sargassum serratifolium Extracts on β-Amyloid Production

β-아밀로이드 단백질 생성에 대한 톱니모자반(Sargassum serratifolium) 추출물의 효과

  • Choi, Min-Woo (Department of Food Science and Nutrition, Pukyong National University) ;
  • Jung, Cha-Gyun (Department of Neurophysiology and Brain Science, Nagoya City University Graduate School of Medical Sciences) ;
  • Kim, Hyeung-Rak (Department of Food Science and Nutrition, Pukyong National University) ;
  • Kim, Jae-Il (Department of Food Science and Nutrition, Pukyong National University)
  • 최민우 (부경대학교 식품영양학과) ;
  • 정차균 (나고야시립대학 대학원의학연구과 뇌신경생리학부) ;
  • 김형락 (부경대학교 식품영양학과) ;
  • 김재일 (부경대학교 식품영양학과)
  • Received : 2017.02.16
  • Accepted : 2017.02.21
  • Published : 2017.02.28

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder of insidious onset that causes gradual loss of memory and cognitive function, and it is the most common form of dementia in the elderly. AD is characterized by neuritic plaques and neurofibrillary tangles in the brain, together with loss of neuronal cells. The major neuropathological hallmark of AD is the accumulation of extracellular neurotoxic ${\beta}-amyloid$ ($A{\beta}$) peptides, such as $A{\beta}1-42$, in the brain. In the present study, we investigated the effect of sargachromenol (SCM), sargaquinoic acid (SQA) and sargahydroquinoic acid (SHQA) isolated from Sargassum serratifoilum ethanol extract (SSE) on $A{\beta}$ production in vitro using APP751-transfected Chinese hamster ovary cells (CHO-751). CHO-751 cells were treated with various concentrations of SSE, SCM, SQA and SHQA, and the level of extracellular $A{\beta}1-42$ was evaluated by enzyme-linked immunosorbent assay. SSE and SHQA reduced the production of $A{\beta}1-42$ in CHO-751 cells. Therefore, SHQA isolated from S. serratifolium has potential as an inhibitor of neurotoxic $A{\beta}$ peptide production.

Keywords

References

  1. Bonet-Costa V, Herranz-Perez V, Blanco-Gandia M, Mas-Bargues C, Ingles M, Garcia-Tarraga P, Rodriguez-Arias M, Minarro J, Borras C, Garcia-Verdugo JM and Vina J. 2016. Clearing amyloid-${\beta}$ through PPAR${\gamma}$-/ApoE activation by genistein is a treatment of experimental Alzheimer's disease. J Alzheimers Dis 51, 701-711. http://dx.doi.org/10.3233/JAD-151020.
  2. Choi BW, Ryu G, Park SH, Kim ES, Shin J, Roh SS, Shin HC and Lee BH. 2007. Anticholinesterase activity of plastoquinones from Sargassum sagamianum: lead compounds for Alzheimer's disease therapy. Phytother Res 21, 423-426. http://dx.doi.org/10.1002/ptr.2090
  3. Corrigan F, Pham CL, Vink R, Blumbergs PC, Masters CL, van den Heuvel C and Cappai R. 2011. The neuroprotective domains of the amyloid precursor protein, in traumatic brain injury, are located in the two growth factor domains. Brain Res 1378, 137-143. http://dx.doi.org/10.1016/j.brainres.2010.12.077.
  4. Da Mesquita S, Ferreira AC, Sousa JC, Correia-Neves M, Sousa N and Marques F. 2016. Insights on the pathophysiology of Alzheimer's disease: the crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system. Neurosci Biobehav Rev 68, 547-562. http://dx.doi.org/doi:10.1016/j.neubiorev.2016.06.014.
  5. de la Mare JA, Lawson JC, Chiwakata MT, Beukes DR, Edkins AL and Blatch GL. 2012. Quinones and halogenated monoterpenes of algal origin show anti-proliferative effects against breast cancer cells in vitro. Invest New Drugs 30, 2187-2200. http://dx.doi.org/10.1007/s10637-011-9788-0.
  6. Endres K and Fahrenholz F. 2012. Regulation of alpha-secretase ADAM10 expression and activity. Exp Brain Res 217, 343-352. http://dx.doi.org/10.1007/s00221-011-2885-7.
  7. Fernando PM, Piao MJ, Hewage SR, Kang HK, Yoo ES, Koh YS, Ko MH, Ko CS, Byeon SH, Mun SR, Lee NH and Hyun JW. 2016. Photo-protective effect of sargachromenol against UVB radiation-induced damage through modulating cellular antioxidant systems and apoptosis in human keratinocytes. Environ Toxicol Pharmacol 43, 112-119. http://dx.doi.org/10.1016/j.etap.2016.02.012.
  8. Goldgaber D, Lerman MI, McBride OW, Saffiotti U and Gajdusek DC. 1987. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 235, 877-880. http://dx.doi.org/10.1126/science.3810169.
  9. Gwon WG, Lee B, Joung EJ, Choi MW, Yoon N, Shin T, Oh CW and Kim HR. 2015. Sargaquinoic acid inhibits TNF-${\alpha}$-induced NF-$\kappa$B Signaling, thereby contributing to decreased monocyte adhesion to human umbilical vein endothelial cells. J Agric Food Chem 63, 9053-9061. http://dx.doi.org/10.1021/acs.jafc.5b04050.
  10. Heneka MT, Golenbock DT and Latz E. 2015. Innate immunity in Alzheimer's disease. Nat Immunol 16, 229-235. http://dx.doi.org/10.3348/kjr.2015.16.2.229.
  11. Hur S, Lee H, Kim Y, Lee BH, Shin J and Kim TY. 2008. Sargaquinoic acid and sargachromenol, extracts of Sargassum sagamianum, induce apoptosis in HaCaT cells and mice skin: its potentiation of UVB-induced apoptosis. Eur J Pharmacol 582, 1-11. http://dx.doi.org/10.1016/j.ejphar.2007.12.025.
  12. Jeon SY, Bae K, Seong YH and Song KS. 2003. Green tea catechins as a BACE1 (beta-secretase) inhibitor. Bioorg Med Chem Lett 13, 3905-3908. http://dx.doi.org/10.1016/j.bmcl.2003.09.018.
  13. Jeon Y, Jung Y, Kim MC, Kwon HC, Kang KS, Kim YK and Kim SN. 2014. Sargahydroquinoic acid inhibits TNF${\alpha}$-induced AP-1 and NF$\kappa$B signaling in HaCaT cells through PPAR${\alpha}$ activation. Biochem Biophys Res Commun 450, 1553-1559. http://dx.doi.org/10.1016/j.bbrc.2014.07.026.
  14. Joung EJ, Lee B, Gwon WG, Shin T, Jung BM, Yoon NY, Choi JS, Oh CW and Kim HR. 2015. Sargaquinoic acid attenuates inflammatory responses by regulating NF-$\kappa$B and Nrf2 pathways in lipopolysaccharide-stimulated RAW264.7 cells. Int Immunopharmacol 29, 693-700. http://dx.doi.org/10.1016/j.intimp.2015.09.007.
  15. Kamei Y and Tsang CK. 2003. Sargaquinoic acid promotes neurite outgrowth via protein kinase A and MAP kinases mediated signaling pathways in PC12D cells. Int J Dev Neurosci 21, 255-262. https://doi.org/10.1016/S0736-5748(03)00068-6
  16. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW and Glabe CG. 2003. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489. http://dx.doi.org/10.1126/science.1079469.
  17. Kim JA, Ahn BN, Kong CS and Kim SK. 2012. Protective effect of chromene isolated from Sargassum horneri against UV-Ainduced damage in skin dermal fibroblasts. Exp Dermatol 21, 630-631. http://dx.doi.org/10.1111/j.1600-0625.2012.01535.x.
  18. Kim SN, Choi HY, Lee W, Park GM, Shin WS and Kim YK. 2008. Sargaquinoic acid and sargahydroquinoic acid from Sargassum yezoense stimulate adipocyte differentiation through PPARalpha/gamma activation in 3T3-L1 cells. FEBS Lett 582, 3465-3472. http://dx.doi.org/10.1016/j.febslet.2008.09.011.
  19. Kim SN, Lee W, Bae GU and Kim YK. 2012. Anti-diabetic and hypolipidemic effects of Sargassum yezoense in db/dbmice. Biochem Biophys Res Commun 424, 675-680. http://dx.doi.org/10.1016/j.bbrc.2012.07.005.
  20. Marr RA and Hafez DM. 2014. Amyloid-beta and Alzheimer's disease: the role of neprilysin-2 in amyloid-beta clearance. Front Aging Neurosci 6, 187-193. http://dx.doi.org/10.3389/fnagi.2014.00187.
  21. Na CH, Jeoun SH, Zhang G, Olson GL and Chae CB. 2007. Inhibition of amyloid ${\beta}$-peptide production by blockage of ${\beta}$-secretase cleavage site of amyloid precursor protein. J Neurochem 101, 1583-1595. http://dx.doi.org/10.1111/j.1471-4159.2006.04441.x.
  22. Nie HZ, Li ZQ, Yan QX, Wang ZJ, Zhao WJ, Guo LC and Yin M. 2011. Nicotine decreases beta-amyloid through regulating BACE1 transcription in SH-EP1-${\alpha}$4${\beta}$2 nAChRAPP695 cells. Neurochem Res 36, 904-912. http://dx.doi.org/10.1007/s11064-011-0420-7.
  23. Oak JH and Lee IK. 2006. Taxonomy of the Genus Sargassum (Fucales, Phaeophyceae) from Korea II. Subgenus Bactrophycus section Halochloa and Repentia. Algae 21, 393-405. https://doi.org/10.4490/ALGAE.2006.21.4.393
  24. Pahlsson P and Spitalnik SL. 1996. The role of glycosylation in synthesis and secretion of beta-amyloid precursor protein by Chinese hamster ovary cells. Arch Biochem Biophys 331, 177-186. http://dx.doi.org/10.1006/abbi.1996.0296.
  25. Paris D, Beaulieu-Abdelahad D, Bachmeier C, Reed J, Ait-Ghezala G, Bishop A, Chao J, Mathura V, Crawford F and Mullan M. 2011. Anatabine lowers Alzheimer's A${\beta}$ production in vitro and in vivo. Eur J Pharmacol 670, 384-391. http://dx.doi.org/10.1016/j.ejphar.2011.09.019.
  26. Park BG, Shin WS, Um Y, Cho S, Park GM, Yeon DS, Kwon SC, Ham J, Choi BW and Lee S. 2008. Selective vasodilatation effect of sargahydroquinoic acid, an active constituent of Sargassum micracanthum, on the basilar arteries of rabbits. Bioorg Med Chem Lett 18, 2624-2627. http://dx.doi.org/10.1016/j.bmcl.2008.03.034.
  27. Perez-Castorena AL, Arciniegas A, Apan MT, Villasenor JL and de Vivar AR. 2002. Evaluation of the anti-inflammatory and antioxidant activities of the plastoquinone derivatives isolated from Roldana barba-johannis. Planta Med 68, 645-647. http://dx.doi.org/10.1055/s-2002-32890.
  28. Sisodia SS and St George-Hyslop PH. 2002. Gamma-secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in? Nat Rev Neurosci 3, 281-290. http://dx.doi.org/10.1038/nrn785.
  29. Thornton E, Vink R, Blumbergs PC and van den Heuvel C. 2006. Soluble amyloid precursor protein alpha reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats. Brain Res 1094, 38-46. http://dx.doi.org/10.1016/j.brainres.2006.03.107.
  30. Tsang CK, Ina A, Goto T and Kamei Y. 2005. Sargachromenol, a novel nerve growth factor-potentiating substance isolated from Sargassum macrocarpum, promotes neurite outgrowth and survival via distinct signaling pathways in PC12D cells. Neuroscience 132, 633-643. http://dx.doi.org/10.1016/j.neuroscience.2005.01.028.
  31. Tsang CK and Kamei Y. 2004. Sargaquinoic acid supports the survival of neuronal PC12D cells in a nerve growth factorindependent manner. Eur J Pharmacol 488, 11-18. http://dx.doi.org/10.1016/j.ejphar.2004.01.033.
  32. Tsang CK, Sagara A and Kamei Y. 2001. Neurite outgrowth promoting substance from a marine alga, Sargassum macrocarpum. In: Animal Cell Technology: From Target to Market. Kluwer Academic Publishers, Dordrecht, Netherlands, 20-22.
  33. Wang L, Waltenberger B, Pferschy-Wenzig EM, Blunder M, Liu X, Malainer C, Blazevic T, Schwaiger S, Rollinger JM, Heiss EH, Schuster D, Kopp B, Bauer R, Stuppner H, Dirsch VM and Atanasov AG. 2014. Natural product agonists of peroxisome proliferator-activated receptor gamma (PPAR${\gamma}$): a review. Biochem Pharmacol 92, 73-89. http://dx.doi.org/10.1016/j.apradiso.2014.06.008.
  34. Weggen S, Rogers M and Eriksen J. 2007. NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development? Trends Pharmacol Sci 28, 536-543. http://dx.doi.org/10.1016/j.tips.2007.09.004.
  35. Xia W, Zhang J, Kholodenko D, Citron M, Podlisny MB, Teplow DB, Haass C, Seubert P, Koo EH and Selkoe DJ. 1997. Enhanced production and oligomerization of the 42-residue amyloid beta-protein by Chinese hamster ovary cells stably expressing mutant presenilins. J Biol Chem 272, 7977-7982. http://dx.doi.org/10.1074/jbc.272.12.7977.

Cited by

  1. Marine natural products vol.36, pp.1, 2019, https://doi.org/10.1039/C8NP00092A